Logo image of NOGN

NOGIN INC (NOGN) Stock Fundamental Analysis

USA - NASDAQ:NOGN - US65528N2045 - Common Stock

0.061 USD
-0.05 (-45.58%)
Last: 12/21/2023, 8:00:02 PM
0.0526 USD
-0.01 (-13.77%)
After Hours: 12/21/2023, 8:00:02 PM
Fundamental Rating

1

Overall NOGN gets a fundamental rating of 1 out of 10. We evaluated NOGN against 30 industry peers in the Broadline Retail industry. NOGN may be in some trouble as it scores bad on both profitability and health. NOGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NOGN had negative earnings in the past year.
NOGN had a negative operating cash flow in the past year.
NOGN Yearly Net Income VS EBIT VS OCF VS FCFNOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M

1.2 Ratios

NOGN's Return On Assets of -82.25% is on the low side compared to the rest of the industry. NOGN is outperformed by 97.06% of its industry peers.
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROIC N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOGN Yearly ROA, ROE, ROICNOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 -400

1.3 Margins

The Gross Margin of NOGN (46.16%) is better than 61.76% of its industry peers.
In the last couple of years the Gross Margin of NOGN has declined.
The Profit Margin and Operating Margin are not available for NOGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
NOGN Yearly Profit, Operating, Gross MarginsNOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 20 -20 40 -40 60

0

2. Health

2.1 Basic Checks

NOGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NOGN remains at a similar level compared to 1 year ago.
Compared to 1 year ago, NOGN has a worse debt to assets ratio.
NOGN Yearly Shares OutstandingNOGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
NOGN Yearly Total Debt VS Total AssetsNOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

NOGN has an Altman-Z score of -7.66. This is a bad value and indicates that NOGN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NOGN (-7.66) is worse than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.66
ROIC/WACCN/A
WACC4.56%
NOGN Yearly LT Debt VS Equity VS FCFNOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

NOGN has a Current Ratio of 0.14. This is a bad value and indicates that NOGN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.14, NOGN is not doing good in the industry: 97.06% of the companies in the same industry are doing better.
NOGN has a Quick Ratio of 0.14. This is a bad value and indicates that NOGN is not financially healthy enough and could expect problems in meeting its short term obligations.
NOGN has a worse Quick ratio (0.06) than 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.06
NOGN Yearly Current Assets VS Current LiabilitesNOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.81% over the past year.
The Revenue for NOGN has decreased by -39.39% in the past year. This is quite bad
NOGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.09% yearly.
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%

3.2 Future

The Earnings Per Share is expected to grow by 26.11% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.87% on average over the next years.
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NOGN Yearly Revenue VS EstimatesNOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NOGN Yearly EPS VS EstimatesNOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOGN. In the last year negative earnings were reported.
Also next year NOGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOGN Price Earnings VS Forward Price EarningsNOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOGN Per share dataNOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as NOGN's earnings are expected to grow with 26.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.11%

0

5. Dividend

5.1 Amount

No dividends for NOGN!.
Industry RankSector Rank
Dividend Yield N/A

NOGIN INC

NASDAQ:NOGN (12/21/2023, 8:00:02 PM)

After market: 0.0526 -0.01 (-13.77%)

0.061

-0.05 (-45.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-22 2023-11-22/dmh
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners173.51%
Ins Owner Change0%
Market Cap688.60K
Revenue(TTM)68.27M
Net Income(TTM)-38875000
Analysts42.86
Price Target1.02 (1572.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.76%
Min EPS beat(2)-88.42%
Max EPS beat(2)-23.09%
EPS beat(4)1
Avg EPS beat(4)-47.28%
Min EPS beat(4)-88.42%
Max EPS beat(4)0.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.37%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-10.35%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)-2.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-60%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.79%
EPS NY rev (1m)-7.04%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.12
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS6.05
BVpS-8.46
TBVpS-8.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.16%
FCFM N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.24%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.06
Altman-Z -7.66
F-Score4
WACC4.56%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-59.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.07%
EBIT Next 3Y34.2%
EBIT Next 5YN/A
FCF growth 1Y-21.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.43%
OCF growth 3YN/A
OCF growth 5YN/A

NOGIN INC / NOGN FAQ

What is the fundamental rating for NOGN stock?

ChartMill assigns a fundamental rating of 1 / 10 to NOGN.


Can you provide the valuation status for NOGIN INC?

ChartMill assigns a valuation rating of 1 / 10 to NOGIN INC (NOGN). This can be considered as Overvalued.


Can you provide the profitability details for NOGIN INC?

NOGIN INC (NOGN) has a profitability rating of 1 / 10.


Can you provide the financial health for NOGN stock?

The financial health rating of NOGIN INC (NOGN) is 0 / 10.